SUKROL LABORATORIES INC. – Trademark Portfolio
Entity Type: 03
SUKROL LABORATORIES INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include SUKROL, KIDS UKROL, VITAL FUERTE, MEGA SUGLUKROL, and VITAKROL MEGAFORT. The owner is based in DEL MAR, CA.
P. O. Box 2577
DEL MAR, CA 920141877
Showing of trademarks Trademarks
Trademark Classifications
SUKROL LABORATORIES INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does SUKROL LABORATORIES INC. have?
SUKROL LABORATORIES INC. has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 4 cancelled.
What trademark classes does SUKROL LABORATORIES INC. file in?
SUKROL LABORATORIES INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SUKROL LABORATORIES INC.'s most well-known trademarks?
SUKROL LABORATORIES INC.'s registered trademark portfolio includes well-known marks such as SUKROL, KIDS UKROL, VITAL FUERTE, MEGA SUGLUKROL, and VITAKROL MEGAFORT. These are among 6 currently registered trademarks in the portfolio.
What is SUKROL LABORATORIES INC.'s trademark registration success rate?
SUKROL LABORATORIES INC. has a 43% trademark registration rate, with 6 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.